531599 Stock Overview
Manufactures and markets pharmaceutical products in India and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 0/6 |
| Past Performance | 5/6 |
| Financial Health | 6/6 |
| Dividends | 5/6 |
FDC Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹484.05 |
| 52 Week High | ₹659.00 |
| 52 Week Low | ₹375.65 |
| Beta | 0.28 |
| 11 Month Change | -8.67% |
| 3 Month Change | -9.66% |
| 1 Year Change | 18.74% |
| 33 Year Change | 67.06% |
| 5 Year Change | 153.36% |
| Change since IPO | 11,222.81% |
Recent News & Updates
Recent updates
Shareholder Returns
| 531599 | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | -2.5% | -0.2% | 0.3% |
| 1Y | 18.7% | 40.5% | 27.3% |
Return vs Industry: 531599 underperformed the Indian Pharmaceuticals industry which returned 40.5% over the past year.
Return vs Market: 531599 underperformed the Indian Market which returned 27.3% over the past year.
Price Volatility
| 531599 volatility | |
|---|---|
| 531599 Average Weekly Movement | 5.3% |
| Pharmaceuticals Industry Average Movement | 6.0% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in IN Market | 9.2% |
| 10% least volatile stocks in IN Market | 4.0% |
Stable Share Price: 531599 has not had significant price volatility in the past 3 months compared to the Indian market.
Volatility Over Time: 531599's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1936 | 6,659 | Nandan Chandavarkar | www.fdcindia.com |
FDC Limited manufactures and markets pharmaceutical products in India and internationally. The company offers specialized formulations for various therapeutic segments, including anti-infective, gastrointestinal, ophthalmic, vitamins, minerals, dietary supplements, cardiac, anti-diabetes, respiratory, gynaecology, dermatology, and analgesics; and anti-oxidants, balanced energy and protein drinks, and vitamins and nutraceuticals, as well as various active pharmaceutical ingredients. It provides its products under the Zifi, Zefu, Zocon, Amodep-AT, Zathrin, Mycoderm, Zoxan, Cotaryl, Pyrimon DF, Zipod, Vitcofol, Ziglim, Ziglim Plus 2, Electral, and Enerzal brand names.
FDC Limited Fundamentals Summary
| 531599 fundamental statistics | |
|---|---|
| Market cap | ₹78.81b |
| Earnings (TTM) | ₹3.17b |
| Revenue (TTM) | ₹20.72b |
24.9x
P/E Ratio3.8x
P/S RatioIs 531599 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 531599 income statement (TTM) | |
|---|---|
| Revenue | ₹20.72b |
| Cost of Revenue | ₹7.53b |
| Gross Profit | ₹13.20b |
| Other Expenses | ₹10.03b |
| Earnings | ₹3.17b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 19.45 |
| Gross Margin | 63.68% |
| Net Profit Margin | 15.28% |
| Debt/Equity Ratio | 0% |
How did 531599 perform over the long term?
See historical performance and comparisonDividends
2.1%
Current Dividend Yield26%
Payout RatioDoes 531599 pay a reliable dividends?
See 531599 dividend history and benchmarks| FDC dividend dates | |
|---|---|
| Ex Dividend Date | Nov 22 2024 |
| Dividend Pay Date | Dec 06 2024 |
| Days until Ex dividend | 0 days |
| Days until Dividend pay date | 14 days |
Does 531599 pay a reliable dividends?
See 531599 dividend history and benchmarks